Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Estetrol-Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia.
Gemzell-Danielsson K, Apter D, Zatik J, Weyers S, Piltonen T, Suturina L, Apolikhina I, Jost M, Creinin MD, Foidart JM. Gemzell-Danielsson K, et al. Among authors: apter d. BJOG. 2022 Jan;129(1):63-71. doi: 10.1111/1471-0528.16840. Epub 2021 Aug 9. BJOG. 2022. PMID: 34245666 Free PMC article. Clinical Trial.
Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials.
Jensen JT, Kaunitz AM, Achilles SL, Zatik J, Weyers S, Piltonen T, Suturina L, Apolikhina I, Bouchard C, Chen MJ, Apter D, Jost M, Foidart JM, Creinin MD. Jensen JT, et al. Among authors: apter d. Contraception. 2022 Dec;116:37-43. doi: 10.1016/j.contraception.2022.07.009. Epub 2022 Jul 31. Contraception. 2022. PMID: 35921870 Free article. Clinical Trial.
Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature.
Palacios S, Regidor PA, Colli E, Skouby SO, Apter D, Roemer T, Egarter C, Nappi RE, Skřivánek A, Jakimiuk AJ, Weyers S, Ács N, Elia D, Gemzell Danielsson K, Bitzer J. Palacios S, et al. Among authors: apter d. Eur J Contracept Reprod Health Care. 2020 Jun;25(3):221-227. doi: 10.1080/13625187.2020.1743828. Epub 2020 Apr 21. Eur J Contracept Reprod Health Care. 2020. PMID: 32312141 Review.
The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial.
Gemzell-Danielsson K, Apter D, Hauck B, Schmelter T, Rybowski S, Rosen K, Nelson A. Gemzell-Danielsson K, et al. Among authors: apter d. PLoS One. 2015 Sep 17;10(9):e0135309. doi: 10.1371/journal.pone.0135309. eCollection 2015. PLoS One. 2015. PMID: 26378938 Free PMC article. Clinical Trial.
A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescents.
Gemzell-Danielsson K, Buhling KJ, Dermout SM, Lukkari-Lax E, Montegriffo E, Apter D. Gemzell-Danielsson K, et al. Among authors: apter d. Contraception. 2016 Jun;93(6):507-12. doi: 10.1016/j.contraception.2016.02.004. Epub 2016 Feb 9. Contraception. 2016. PMID: 26872720 Free article. Clinical Trial.
156 results